Aileron Therapeutics, Inc.
PEPTIDOMIMETIC MACROCYCLES AND FORMULATIONS THEREOF
Last updated:
Abstract:
Aqueous pharmaceutical formulations, for parenteral administration, comprising peptidomimetic macrocycle or a pharmaceutically acceptable salt thereof wherein the peptidomimetic macrocycle binds to MDM2 and/or MDMX proteins are disclosed. Also disclosed are methods of treating diseases and disorders using the aqueous pharmaceutical formulations disclosed herein.
Status:
Application
Type:
Utility
Filling date:
6 Nov 2020
Issue date:
30 Sep 2021